Achyut Healthcare Secures BSE Approval for ₹3.48 Crore Share Issue

Achyut Healthcare Limited has received approval from the Bombay Stock Exchange (BSE) to list 58 lakh equity shares resulting from its preferential issue. This move is set to raise approximately ₹3.48 crore, strengthening the company's financial position and share capital. The shares are to be listed at a minimum price of ₹6 each.

Previous Fundraising Efforts

This is not the first time Achyut Healthcare has raised funds through preferential share issues. In August 2023, the company raised ₹2.38 crore by issuing 20 lakh shares at ₹11.90 each. Prior to that, in January 2023, Achyut Healthcare secured ₹2.25 crore by allotting 10 lakh shares at ₹22.50 per share.

Impact on the Company

The capital infusion is expected to enhance Achyut Healthcare's financial standing, potentially supporting future growth initiatives or working capital needs. Following the listing, the company's total paid-up share capital will increase, and its shareholding pattern will be updated. This fundraising is anticipated to improve liquidity and financial flexibility, bringing the company closer to executing its growth strategy.

Potential Compliance Risks

Achyut Healthcare faces potential fines from the Securities and Exchange Board of India (SEBI) if it fails to adhere to listing procedures or submit its shareholding patterns for XBRL filing on time.

Industry Context

Achyut Healthcare operates within the pharmaceutical sector. Its peers include companies like Bliss GVS Pharma Ltd. and Alpa Laboratories Ltd., which also focus on manufacturing and marketing pharmaceutical products and navigate similar regulatory environments. However, performance metrics and fundraising strategies often differ significantly among these micro-to-small cap entities.

Next Steps for Achyut Healthcare

The company must now secure definitive trading approval from the BSE for the newly listed shares. Confirmation from NSDL and CDSL regarding the crediting and admission of these shares into the depository system is also pending. A critical step involves filing the application for trading approval with the BSE within seven working days of receiving the listing approval. Depending on its strategy, Achyut Healthcare may also apply for listing approval on the National Stock Exchange.